Zhongchao Inc. Collaborates with a Public Health Foundation to Support Sustainable and Effective Cancer Treatments

SHANGHAI, Dec. 11, 2023 /PRNewswire/ — Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or…

"K-Beauty Tech Shines in the U.S." APR Corp. to Showcase Beauty Device Technology at CES 2024

The world’s largest IT-Home Appliance Trade Show, "CES 2024" in Las Vegas,…

Yingli Pharma presents a pivotal Phase 2 study data evaluating linperlisib in relapsed or refractory peripheral T-cell lymphoma in an oral session at the American Society of Hematology 2023 Annual Meeting

Linperlisib achieved Overall Response Rate of 48% with 30% being Complete Response…

Global Times: Renowned French director Luc Besson brings latest work 'Dogman' to China

BEIJING, Dec. 11, 2023 /PRNewswire/ — When Luc Besson’s latest film Dogman hits…

Mabwell Announces the CDE Approval of Novel Nectin-4 Targeting ADC for Phase III Clinical Trial

SHANGHAI, Dec. 11, 2023 /PRNewswire/ — Mabwell (688062.SH), an innovative biopharmaceutical company…

INNOVATION TO INSPIRE, A WONDEROUS FUTURE | Tianma 2023 Global Innovation Conference, Seven Innovative Achievements Unveiled

XIAMEN, China, Dec. 11, 2023 /PRNewswire/ — On November 27th, Tianma Innovation Conference…

Keppel partners AM Green to explore biogenic carbon-based sustainable fuels opportunities in Asia and the Middle East

SINGAPORE and DUBAI, UAE, Dec. 11, 2023 /PRNewswire/ — Keppel Corporation Limited…